Forward P/S Multiple: STRATA Skin Sciences Inc. (SSKN)
STRATA Skin Sciences (SSKN) supplies laser systems for the treatment of vitiligo and psoriasis to clinics. The forward P/S ratio reflects market expectations, where 0.00 becomes the new value of the metric. Revenue is based on the sale of devices and consumables, which stabilizes cash flow. However, the limited capital of physicians restricts the growth of procedure fees, weakening the issuer's pricing power.
Summary analytical data breakdowns for strataskinsciences.com (SSKN)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- debt and liquidity data:
Total Debt to Capital STRATA Skin Sciences|SSKN - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital STRATA Skin Sciences, Inc.|SSKN - Company Aggregate Debts|Debt to Book Capitalization Ratio STRATA Skin Sciences, Inc.|SSKN - Company Long-Term Debt|Company Current Liabilities STRATA Skin Sciences|Quick Ratio strataskinsciences.com
- financial results and valuation multiples details:
SSKN - Company Net Income|Expected Profit STRATA Skin Sciences|SSKN - Market Cap to Net Income Ratio|Projected Price to Earnings STRATA Skin Sciences, Inc.|SSKN - PEG Multiple|EV/EBITDA Multiple STRATA Skin Sciences, Inc.|SSKN - Operating income before deduction of amortization|Earnings per share for the last twelve months STRATA Skin Sciences|SSKN - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months strataskinsciences.com|SSKN - Net earnings per share growth this year|Earnings growth forecast for next year STRATA Skin Sciences
- sales and revenue indicators:
Fundamental company analysis:SSKN (STRATA Skin)
Moderate cyclicality in demand for STRATA Skin Sciences (SSKN) laser systems and stable revenue from consumables make the capitalization-to-forecasted-revenue ratio a key tool for assessing business resilience. The trend in the expected price-to-sales ratio allows investors to determine the asset's current margin of safety and promptly identify either the emergence of an investment discount or a systemic deterioration of the company's fundamental indicators.
Who STRATA Skin Sciences competes with
Price-to-Projected Revenue Ratio Dexcom DXCM|PEN - Forward Price-to-Revenue Multiple|Novanta Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Haemonetics Company|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|CNMD (CONMED) - Forward P/S Multiple|Pulse Biosciences Inc (PLSE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple INMD|Forward Price-to-Revenue Multiple Picard Group PMI|Forward P/S Multiple SRDX (Surmodics, Inc.)|Forward P/S Multiple senseonics.com SENS|NPCE - Price-to-Projected Revenue Ratio|TCMD: Price-to-Projected Revenue Ratio|SNWV (SANUWAVE Health, Inc.) - Forward Price-to-Revenue Multiple|Outset Medical Corp - Forward Price to Sales|ELMD (SmartVest) - Forward P/S Multiple|Market Cap to Future Revenue Ratio lensar.com LNSR|Price-to-Projected Revenue Ratio AVITA Medical (RCEL)|profoundmedical.com (PROF) - Projected Price to Revenue|Baird Medical - Forward Price-to-Revenue Multiple|Forward P/S Multiple EDAP TMS SA EDAP|Bovie Medical - Forward P/S Multiple|Market Cap to Expected Sales Ratio IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Price-to-Projected Revenue Ratio|Future Price to Revenue TELA (TELA Bio)|Price-to-Projected Revenue Ratio CytoSorbents Corp|Forward Price-to-Revenue Multiple Sensus (SRTS)|Forward P/S Multiple ZYXI|ECOR - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Vicarious Surgical RBOT|IINN: Market Cap to Projected Revenue|ICU: Forward Price-to-Revenue Multiple|IRIDEX Corporation - Price to Expected Revenue Ratio|ibs.inc (INBS) - Price-to-Projected Revenue Ratio|XAIR - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple PFSA|GCTK (glucotrack.com) - Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio NanoVibronix (NAOV)|VERO (Venus Concept Corporation) - Forward Price to Sales|Forward P/S Multiple NUWE (Nuwellis, Inc.)|Forward P/S Multiple aethlonmedical.com AEMD|ASXC: Forward Price-to-Revenue Multiple|Avinger Inc. - Price to Expected Revenue Ratio|BSGM: Forward P/S Multiple|Cutera Inc (CUTR) - Forward P/S Multiple|Forward Price-to-Revenue Multiple KNW|NARI: Forward Price to Sales|Price-to-Projected Revenue Ratio Nevro (NVRO)|Market Cap to Expected Sales Ratio reshapelifesciences.com|Price-to-Projected Revenue Ratio Silk Road Medical Inc. SILK
